Zdrowie i gospodarka · 23.07.2001
Hematology and Pathology Devices; Reclassification of Automated Differential Cell Counters; Correction
The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of May 9, 2001 (66 FR 23634). The document proposes to reclassify from class III (premarket approval) to class II (special controls) the automated differential cell counter (ADCC). The document published inadvertently with the incorrect docket number. This document corrects that error.